What is the equity of Bruker this year?
Bruker has equity of 1.38 B USD this year.
Bruker Equity 2024
Bruker Equity
1.38 B USD
Ticker
BRKR
ISIN
US1167941087
WKN
813534
In 2024, Bruker's equity was 1.38 B USD, a 23.65% increase from the 1.11 B USD equity in the previous year.
Bruker Aktienanalyse
What does Bruker do?
The Bruker Corporation is a leading manufacturer of scientific instruments and solutions for the life science, pharmaceutical, biotech, forensic, clinical, and chemical industries. The company was founded in 1960 and is headquartered in Billerica, Massachusetts, USA. Bruker is divided into four main business segments: Scientific Instruments, Energy and Supercon Technologies, Optics, and Advanced Systems. The products and solutions are used in research, development, and industrial processes in more than 100 countries worldwide. The Scientific Instruments segment offers a wide range of analytical instruments, including X-ray spectroscopy, mass spectrometry, infrared spectroscopy, NMR, microtomography, and electron microscopy, as well as automated laboratory equipment. These instruments are used to investigate and analyze materials, processes, and organisms to gain insights into molecular, atomic, and microscopic connections. The Energy and Supercon Technologies segment is involved in the research and development of innovative technologies and products that contribute to energy generation, transmission, and storage. This includes superconducting magnets, magnetic resonance imaging systems, and NMR spectrometers combined with high-field magnet systems. In the Optics segment, Bruker develops and manufactures optical technologies and components for applications in the life science, microelectronics, semiconductor, military, and aerospace industries. The products range from high-performance microscopes and spectrometers to laser interferometry systems. In the Advanced Systems segment, Bruker offers automated system solutions for semiconductor manufacturing, microelectronics, food technology, and clinical laboratories, which increase production efficiency, save resources, and improve product quality. The systems can range from handling robots to process control systems and quality inspection solutions. Bruker's products have a central role in research, development, and manufacturing of drugs and medical devices, as well as in material and environmental analysis and other application areas. The company's focus is on the research and development of innovative technologies and products for the future. In recent years, Bruker has also invested in the field of artificial intelligence (AI) and machine learning algorithms to further improve the analysis and data evaluation of experimental results. Thanks to these advancements, Bruker is able to be a pioneer in the research and development of cutting-edge applications and solutions. Overall, Bruker is an important player in the analytical instrument industry with a wide range of products that are used worldwide in a large number of application areas. The company provides innovative solutions for a wide range of scientific and industrial needs and drives continuous progress in various industries. Bruker ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Bruker's Equity
Bruker's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bruker's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Bruker's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Bruker's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Bruker’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Bruker stock
What was the equity of Bruker compared to the previous year?
The equity of Bruker has increased/decreased by 23.65% increased compared to the previous year.
What impact does a high equity have on investors of Bruker?
A high equity is advantageous for investors of Bruker as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Bruker?
A low equity can be a risk for investors of Bruker, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Bruker affect the company?
An increase in equity of Bruker can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Bruker affect the company?
A reduction in equity of Bruker can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Bruker?
Some factors that can affect the equity of Bruker include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Bruker so important for investors?
The equity of Bruker is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Bruker take to change the equity?
To change equity, Bruker can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Bruker pay?
Over the past 12 months, Bruker paid a dividend of 0.2 USD . This corresponds to a dividend yield of about 0.31 %. For the coming 12 months, Bruker is expected to pay a dividend of 0.25 USD.
What is the dividend yield of Bruker?
The current dividend yield of Bruker is 0.31 %.
When does Bruker pay dividends?
Bruker pays a quarterly dividend. This is distributed in the months of December, March, July, September.
How secure is the dividend of Bruker?
Bruker paid dividends every year for the past 13 years.
What is the dividend of Bruker?
For the upcoming 12 months, dividends amounting to 0.25 USD are expected. This corresponds to a dividend yield of 0.38 %.
In which sector is Bruker located?
Bruker is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bruker kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bruker from 9/16/2024 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.
When did Bruker pay the last dividend?
The last dividend was paid out on 9/16/2024.
What was the dividend of Bruker in the year 2023?
In the year 2023, Bruker distributed 0.2 USD as dividends.
In which currency does Bruker pay out the dividend?
The dividends of Bruker are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Bruker stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Bruker
Our stock analysis for Bruker Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bruker Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
